Pharmanza

Anand, India
Produces and supplies veterinary drugs, antibiotics, and supplements for animal health.

About Pharmanza

Pharmanza is a Healthcare company based in Anand (India). It produces and supplies veterinary drugs, antibiotics, and supplements for animal health. It operates on a B2B model. The company has 119 employees. Its Indian entity Pharmanza (India) Private Limited reported revenue of β‚Ή67.74 Cr. Pharmanza offers products and services including Antibiotics, Anathematic Formulations, Feed Supplements, Analgesics, and Anti-Infective. Its focus areas include Pharmaceuticals, Veterinary, Herbal Products and Animal Health Formulations. Its competitors include Zoetis, Ceva, PetMedix, QBiotics and Hester Biosciences and 5 more; 8 of its 10 listed competitors have raised funding.

Company details

Pharmanza (india) Is A Leading Veterinary Pharmaceutical Company Based In India, Specializing In Manufacturing A Wide Range Of Therapeutic Formulations Such As Antibiotics, Anathematic Drugs, Analgesics, Feed Supplements, And Anti-infectives. They Operate From Advanced Facilities In Gujarat That Adhere To International Gmp, Iso, And Who Standards, Ensuring High-quality And Affordable Products. The Company Emphasizes Dedicated Customer Service And Compliance With Global Environmental Guidelines, Serving Clients In The Veterinary Sector.

  • Headquarters Anand, India
  • Employees 119
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website pharmanza.com
  • Legal Name Pharmanza (India) Private Limited
  • Date of Incorporation 15 Jan, 2009
  • Jurisdiction Khambhat, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹67.74 Cr

    FY 2025 · +21% YoY

  • Net Profit
    ₹3.80 Cr

    FY 2025 · 6% margin

  • EBITDA
    ₹6.32 Cr

    FY 2025 · 9% margin

  • Employee Count
    119

Products & Services of Pharmanza

Pharmanza offers a comprehensive portfolio of products and services, including Antibiotics, Anathematic Formulations, Feed Supplements, Analgesics, and Anti-Infective.

Antibiotics
Veterinary Pharmaceuticals

Drugs for treating bacterial infections in animals

Anathematic Formulations
Parasite Control

Products to eliminate parasites in livestock

Feed Supplements
Animal Nutrition

Nutritional aids to enhance animal growth and health

Analgesics
Pain Management

Medications for relieving pain in veterinary applications

Anti-Infective
Infection Treatment

Formulations to combat various infections in animals

Board of directors of Pharmanza (India) Private Limited (Pharmanza)

Pharmanza (India) Private Limited is the primary company behind Pharmanza. The boards of the 2 registered companies of Pharmanza currently have 6 directors; the longest-serving is Ashish Surendrabhai Patel, appointed in 2004. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ashish Surendrabhai Patel
DIN 01309384
Director27 Sep 200422 yrsPharmanza Herbal Private Limited
Hardik Ravindrabhai Patel
DIN 00357469
Director27 Sep 200422 yrsPharmanza Herbal Private Limited, Pharmanza (India) Private Limited
Bhupendrabhai Jivabhai Patel
DIN 01785019
Director27 Sep 200422 yrsPharmanza Herbal Private Limited, Pharmanza (India) Private Limited
Lal Lachhmandas Hingorani
DIN 01785030
Director27 Sep 200422 yrsPharmanza Herbal Private Limited, Pharmanza (India) Private Limited
Kruti Viral Shah
DIN 09464207
Director10 Nov 20232 yrs 11 moPharmanza (India) Private Limited
Chetnaben Vijaykumar Shah
DIN 10417078
Director06 Dec 20232 yrs 10 moPharmanza Herbal Private Limited

People of Pharmanza

2 people are tracked at Pharmanza (2 in leadership); the tracked headcount is 119.

NameRoleGroup
Vijay Shah
OwnerLeadership
OwnerLeadership
Premium access

Complete people profiles for Pharmanza

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Pharmanza

Figures of Pharmanza (India) Private Limited, the primary company behind Pharmanza, for FY 2025. Revenue was ₹67.74 Cr (+21% year on year). Net profit was ₹3.80 Cr (6% margin). EBITDA was ₹6.32 Cr (9% margin). Revenue has grown at a compounded annual rate of +8% over three years and +15% over five years.

  • ₹67.74 CrRevenue · FY 2025 · +21% YoY
  • ₹3.80 CrNet profit · 6% margin
  • ₹6.32 CrEBITDA · 9% margin
  • ₹2.50 CrPaid-up capital
  • 119Employees (provident fund records)
  • +8%Revenue CAGR, 3 years
  • +15%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Pharmanza (India) Private Limited are on its company page.

Premium access

Detailed financial statements for Pharmanza

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Pharmanza

Pharmanza has 10 listed competitors in our database, 8 of them funded. They include Zoetis, Ceva, PetMedix, QBiotics and Hester Biosciences, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
zoetis.com2012Brussels, Belgium–9,200
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
ceva.com1999Libourne, France$214.35M–
Animal health therapeutics are developed and supplied globally by Ceva.
petmedix.com2017Babraham, United Kingdom$47.46M44
Developer of monoclonal antibody therapeutics for pets
qbiotics.com2000Brisbane, Australia$98.07M–
Small molecules from plant extracts are developed for medical applications.
hester.in1987Ahmedabad, India–702
Manufacturer of animal vaccines and healthcare products
bio-sourcing.com2014Liege, Belgium$17.36M–
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
kindredbio.com2012Burlingame, United States$6.9M64
Veterinary antibodies for cats, dogs, and horses are developed.
vjtbio.com2016Haidian, China$14.92M–
Protein-based biopharmaceuticals for animal disease treatment are developed.
thevaccinegroup.com2017Plymouth, United Kingdom$753,99111
Herpesvirus-based animal vaccines are developed against infectious diseases.
bactana.com2016Farmington, United States$1.76M–
Proprietary microbiome technology is developed for companion and food animals.
Premium access

Detailed competitors of Pharmanza

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Veterinary Healthcare & Products

10 companies that operate in the same segment as Pharmanza (Veterinary Healthcare & Products), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
A chain of veterinary hospitals is operated nationwide.
1986Los Angeles, California, United States–USD 5.96 B29,000
Chain of veterinary hospital
2012Westport, United States–––
Diagnostics and pharmaceuticals for companion animals are developed.
2015Ann Arbor, Michigan, United States–USD 32.03 M152
Manufacturer and distribution animal veterinary products
1983Westbrook, Maine, United States–USD 4.3 B11,000
Animal health pharmaceuticals, vaccines, and diagnostics are developed and supplied.
1968Carros, Provence-alpes-cote D'azur, France–USD 1.51 M963
A chain of veterinary hospitals is operated nationwide by BluePearl.
1996Tampa, Florida, United StatesUSD 23.43 MUSD 1.55 K6,371
Provider of veterinary healthcare services
2011Keynsham, United KingdomUSD 4.73 B––
Veterinary food and medicines products are provided for animal health.
1954Greenfield, United States–USD 4.71 B9,450
Manufacturer and provider of animal health products and services
2001Tianjin, ChinaUSD 6.99 MUSD 484.22 M2,900
Veterinary Products - Formulations & APIs - Manufacturer & Supplier
2013Visakhapatnam, Andhra Pradesh, IndiaUSD 20 MUSD 44.35 M850
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pharmanza

Pharmanza is headquartered in Anand, India. It is registered at Anand, Gujarat, India.

Pharmanza has 119 employees.

The primary company behind Pharmanza, Pharmanza (India) Private Limited, reported revenue of β‚Ή67.74 Cr for FY 2025, up 21% year on year.

Pharmanza (india) Is A Leading Veterinary Pharmaceutical Company Based In India, Specializing In Manufacturing A Wide Range Of Therapeutic Formulations Such As Antibiotics, Anathematic Drugs, Analgesics, Feed Supplements, And Anti-infectives. They Operate From Advanced Facilities In Gujarat That Adhere To International Gmp, Iso, And Who Standards, Ensuring High-quality And Affordable Products. The Company Emphasizes Dedicated Customer Service And Compliance With Global Environmental Guidelines, Serving Clients In The Veterinary Sector.

Pharmanza's top competitors include Zoetis, Ceva and QBiotics.

Pharmanza offers Antibiotics, Anathematic Formulations, Feed Supplements, Analgesics, and Anti-Infective.

Pharmanza is associated with 2 legal entities: Pharmanza (India) Private Limited, Pharmanza Herbal Private Limited.

The legal entities of Pharmanza currently have 6 directors, including Ashish Surendrabhai Patel, Hardik Ravindrabhai Patel, Bhupendrabhai Jivabhai Patel and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available